Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.
NCT ID: NCT04095377
Last Updated: 2022-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
875 participants
OBSERVATIONAL
2019-03-24
2022-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Pilot - Hybrid EEG/fMRI Neurofeedback in Depressed Patients
NCT04450186
Study of Eye Movements as Markers of the Physiological, Cerebral and Cognitive State of Healthy Subjects
NCT04325971
EEG Objectification in Neuropsychiatry
NCT01476228
Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury
NCT02878577
Neurofeedback in Patients With Frontal Brain Lesions
NCT02957695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
QuantalX Neuroscience is intending to use the above mentioned data in order to improve DELPhI, an algorithm for the analysis of EEG recordings in response to magnetic stimulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
CVA
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
Hammorhage
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
TBI
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
Concussion
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
Fibromyalgia
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
ABD
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
ADHD
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
MCI
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
DEMENTIA
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
COGNITIVE IMPAIRMENT
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
COGNITIVE DECLINE
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
MS
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention, this is a retrospective study.
No intervention, this is a retrospective study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects that performed at least one EEG test as a part of their hyperbaric treatment at Sagol center Asaf-Harophe.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
QuantalX Neuroscience
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asaf-Harophe
Rishon LeZiyyon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0292-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.